You pretty much nailed  it cityslicker99.

Can you just imagine a competent management team that built the "RVX epigenetic leadership" brand and a NASDAQ listing to raise funds efficiently.

It's been done by a Montreal based biotech called Repare Therapeutics.

Unfortunately it probably won't happen for us. But I still believe the science will win eventually. It may not be to the benefit of us retail investors.

Best of luck. I've been in for 10 plus years and I'm not letting go in spite of Don's false promises. At some point someone will be able to tap the value of this leading compound.

I often wonder why Eastern has stopped supporting RVX through  to a conclusion.

GLTA and Happy Thanksgiving to all.

Toinv